Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merchant, J. L.
Right arrow Articles by Okada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merchant, J. L.
Right arrow Articles by Okada, M.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:2456S-2460S, July 2003


Supplement: Nutritional Genomics and Proteomics in Cancer Prevention

ZBP-89 Mediates Butyrate Regulation of Gene Expression1 ,2

Juanita L. Merchant*,{dagger},3, Longchuan Bai* and Morihiro Okada*

Departments of * Internal Medicine and {dagger} Physiology, University of Michigan, Ann Arbor, MI 48109

3 To whom correspondence should be addressed. E-mail: merchanj{at}umich.edu.

Inducible p53-independent regulation of the cyclin-dependent kinase inhibitor p21Waf1 transcription is mediated through its proximal GC-rich sites. Prior studies have shown that Sp1, Sp3 and the histone acetyltransferase coactivator p300 are components of the complexes that bind to these sites. Although Sp1 and Sp3 collaborate with p300, a direct interaction between Sp1 and p300 does not occur. Zinc-finger binding protein-89 (ZBP-89, also known as BFCOL1, BERF-1 and ZNF-148) is a Krüppel-type zinc-finger transcription factor that binds to the same GC-rich sequences as Sp1. We sought to determine whether ZBP-89 is a target of p300 during butyrate induction of p21Waf1. This review summarizes the evidence that supports a crucial role for ZBP-89 in butyrate regulation of p21Waf1. Adenovirus-mediated expression of ZBP-89 in HT-29 cells reveals that ZBP-89 potentiates butyrate induction of endogenous p21Waf1 gene expression. DNA-protein interaction assays demonstrate that Sp1, Sp3 and ZBP-89 bind the p21Waf1 promoter at -245 to -215. Coprecipitation assays reveal that p300 preferentially binds to the N-terminus of ZBP-89. ZBP-89 also induces p21Waf1 through stabilization of p53. Although ZBP-89 binds mutant and wild-type p53, only wild-type p53 is stabilized. Moreover, mutant p53 shifts the subnuclear location of ZBP-89 to the nuclear periphery, which is a domain rich in heterochromatin. This finding led to the conclusion that mutant p53 exerts a dominant negative effect on ZBP-89. We propose that gene silencing by mutant p53 might be mediated by sequestering ZBP-89 within heterochromatin regions at the nuclear periphery. Overall, ZBP-89 is a butyrate-regulated coactivator of p53 and is able to induce p21Waf1 gene expression through both p53-dependent and -independent mechanisms to inhibit cell growth.


KEY WORDS: • p53 • p21Waf1 • zinc finger • apoptosis • p300 • heterochromatin




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
R Holm, S Knopp, R Kumar, J Lee, J M Nesland, C Trope, and D F Callen
Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis
J. Clin. Pathol., January 1, 2008; 61(1): 59 - 63.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. R. Kiela, N. Kuscuoglu, A. J. Midura, M. T. Midura-Kiela, C. B. Larmonier, M. Lipko, and F. K. Ghishan
Molecular mechanism of rat NHE3 gene promoter regulation by sodium butyrate
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C64 - C74.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L. Zhang and G. J Barritt
TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
Endocr. Relat. Cancer, March 1, 2006; 13(1): 27 - 38.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by American Society for Nutrition